PR Domain Containing 9 (PRDM9) (Middle Region) Peptide
PRDM9
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all PRDM9 products
- PRDM9 (PR Domain Containing 9 (PRDM9))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PRDM9 antibody (Catalog #: ARP35967_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PRDM9 (PR Domain Containing 9 (PRDM9))
- Background
-
The PR domain is a protein-protein interaction module of about 100 amino acids. PR domain-containing proteins, such as PRDM9, are often involved in transcriptional regulation.The PR domain is a protein-protein interaction module of about 100 amino acids. PR domain-containing proteins, such as PRDM9, are often involved in transcriptional regulation (Jiang and Huang, 2000 [PubMed 10668202]).[supplied by OMIM].
Alias Symbols: PFM6, MSBP3, PRMD9, ZNF899, MEISETZ
Protein Size: 894 - Molecular Weight
- 103 kDa
- Gene ID
- 56979
- NCBI Accession
- NM_020227, NP_064612
- UniProt
- Q9NQV7
-
You are here:
